MWNA
RCEL icon

Marshall Wace North America’s Avita Medical RCEL Stock Holding History

Marshall Wace North America’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,212
Closed -$333K – 1660
2021
Q2 		$333K Buy
+16,212
New +$319K ﹤0.01% 1262

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace North America's RCEL Position: Q3 2021 in Review

Marshall Wace North America sold out of Avita Medical (RCEL) in Q3 2021, closing a stake of 16,212 shares — an estimated $333K sold.

Marshall Wace North America first reported a position in RCEL in Q2 2021 and held it in 1 quarter. The position peaked at $333K in Q2 2021. 69 funds tracked by Wall St. Rank hold RCEL as of Q3 2021.

  • Marshall Wace North America reported no remaining Avita Medical position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 16,212 Avita Medical shares in Q3 2021, an estimated $333K.
  • Marshall Wace North America first reported a position in Avita Medical in Q2 2021 and held it in 1 quarter.
  • Marshall Wace North America's Avita Medical position peaked at $333K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Avita Medical as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.